A serine protease inhibitor, N-α-tosyl-L-lysine chloromethyl ketone, prolongs rat hepatic allograft survival

Journal of Surgical Research

Volumn 96, Issue 2, 2001, Pages 296-303

  Zhang, Jia Lin ^a   Yamaguchi, Yasuo ^a   Mori, Katsutaka ^a   Okabe, Kazutoshi ^a   Hidaka, Hideki ^a   Ohshiro, Hajime ^a   Uchino, Schinichiro ^a   Ishihara, Kohjiroh ^a   Furuhashi, Takashi ^a   Yamada, Shinwa ^b   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Liver transplantation; N tosyl L lysine chloromethyl ketone (TLCK); Rat; Serine protease inhibitor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; PERFORIN; SERINE PROTEINASE INHIBITOR; TOSYLLYSYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DNA SYNTHESIS; DOSE RESPONSE; DRUG INFUSION; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPH NODE CELL; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

EID: 0035747025     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.6065     Document Type: Article

References (57)

1. CD4 monoclonal antibodies in organ transplantation: A review of progress
2. The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection
3. + cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation
4. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes
5. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection
6. Nuclear transport of granzyme B (fragmentin-2): Dependence of perforin in vivo and cytosolic factors in vitro
7. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization
8. Perforin and granzyme B: Cytolytic proteins upregulated during rejection of rat small intestine allografts
9. The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction
10. Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection
11. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts
12. Kinetic characterization of brush border membrane proteases in relationship to mucosal architecture by section biochemistry
13. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade
14. Proteolysis, proteasomes and antigen presentation
15. N-α-Tosyl-L-lysine chloromethyl ketone and N-α-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C
16. Studies on the mechanism of NK cell lysis
17. Modification of hyperacute rejection of sheep kidney heterografts in the dog using a trypsin inhibitor
18. The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes
19. The site of action of N-α-tosyl-L-lysyl-chloromethyl-ketone (TLCK) on cloned cytotoxic T lymphocytes
20. Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat
21. A technique for orthotopic reduced-size hepatic transplantation combined with ex vivo liver cut down in the rat
22. Banff schema for grading liver allograft rejection: An international consensus document
23. A comparison of membrane markers on rat cytotoxic cells
24. In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats
25. Splenic outer periarterial lymphoid sheath (PALS): An immunoproliferative microenvironment constituted by antigen-laden marginal metallophils and ED2-positive macrophage in the rat
26. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
27. Characterization of the production of monocyte chemoattractant protein-1 and IL- 8 in an allogeneic immune response
28. Heightened intragraft CTL gene expression in acutely rejecting renal allografts
29. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients
30. Protease inhibitors diminish lymphocyte stimulation in vitro
31. Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor
32. 2+ and IL- 2 production in activated Jurkat T cells
33. Fas ligand, tumor necrosis factor-α expression, and apoptosis during allograft rejection and tolerance
34. Intragraft cytokine expression and tolerance induction in rat renal allografts
35. Tosylphenylalanine chloromethyl ketone inhibits TNF-α mRNA synthesis in the presence of activated NF-kappa B in RAW 264.7 macrophages
36. Taurine blunts LPS-induced increases in intracellular calcium and TNF-α production by Kupffer cells
37. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection
38. Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells
39. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-α genes in rejecting skin allografts
40. Analysis of effector mechanisms in murine cardiac allograft rejection
41. Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody
42. Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection
43. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
44. + cytotoxic T lymphocytes
45. Human lymphokine-activated killer (LAK) cells: III. Effect of L-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: Possible protease involvement of monocytes, natural killer cells and LAK cells
46. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors
47. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers
48. The suppression of T cell function and NF-kappa B expression by serine protease inhibitors is blocked by N-acetylcysteine
49. Complement component C3 production in IL-1β-stimulated human intestinal epithelial cells is blocked by NF-kappa B inhibitors and by transfection with ser 32/36 mutant IkappaB α
50. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: Possible role for NF-kappa B
51. Allograft rejection in pediatric recipients of living related liver transplants
52. Role of transcriptional activation of I kappa Bα in mediation of immunosuppression by glucocorticoids
53. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
54. Suppression of TNF-α-induced apoptosis by NF-kappa B
55. NF-kappa B antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
56. Blocking NF-kappa B in the liver: The good and bad news